Resistin concentrations in serum and stifle synovial fluid from normal and cruciate deficient dogs with osteoarthritis. Issue 6 (29th May 2020)

• Record Type: Journal Article
• Authors: Kleine, Stephanie A.; Gogal, Robert M.; Krunkosky, Thomas M.; Sanderson, Sherry L.; George, Clinton; Norton, Megan; Budsberg, Steven C.
• Is Part Of: Veterinary surgery. Volume 49:Issue 6(2020)
• Page Start: 1164
• Page End: 1173
• Publication Date: 2020-05-29
• Subjects: Veterinary surgery -- Periodicals; Veterinary Medicine -- Periodicals; Surgery -- Periodicals; Societies, Medical -- Periodicals; 636.0897
• DOI: 10.1111/vsu.13450
• Languages: English
• ISSNs: 0161-3499

Abstract

Abstract: Objective: To compare synovial fluid (SF) resistin concentrations in healthy dogs to dogs with osteoarthritis (OA) secondary to cranial cruciate ligament (CrCL) injury and to correlate resistin concentrations with body condition score (BCS) and evaluate resistin release from peripheral blood mononuclear cells (PBMC) and adipocytes. Study design: Controlled, prospective, clinical study Animals: Thirty‐nine client‐owned dogs, 13 healthy and 26 with secondary OA, were enrolled. Blood was collected from six healthy purpose‐bred dogs for PBMC culture. An additional six mixed‐breed dogs were used for adipocyte collection and culture. Methods: Resistin concentrations were measured with a canine‐specific enzyme‐linked immunoabsorbent assay. Resistin was compared between healthy SF and OA SF with Student's t test. Correlation of resistin concentrations to BCS was performed. Peripheral blood mononuclear cells and adipocytes were cultured under three conditions: negative control, lipopolysaccharide, and concanavalin A (Con A). A linear mixed model was used to determine differences in resistin concentrations among treatments. Results: Resistin concentrations in OA SF were comparable to healthy SF. Neither serum nor SF resistin was correlated with BCS. Cultured PBMC stimulated with Con A released resistin, while adipocytes did not. Conclusion: Neither serum nor SF resistin were altered in dogs with OA secondary to CrCL insufficiency. In addition, resistin was not correlated with canine body fat and did not appear to function as adipocytokine in the dog. Clinical significance: Resistin may not be involved in the pathogenesis of OA. However, resistin may be important in inflammation because it is released from inflammatory cells.